----

----

| Nevada                               | 80-0159248               |
|--------------------------------------|--------------------------|
| (State      or other jurisdiction of | (I.R.S.      Employer    |
| incorporation      or organization)  | Identification      No.) |

| Yes   x | No   o |
|------------------------|-----------------------|

| Yes   o | No   x |
|------------------------|-----------------------|

| Large      accelerated filer o                     |   | Accelerated      filer o         |
|----------------------------------------------------|--------|---------------------------------------|
|                                               |   |                                  |
| Non-accelerated      filer o                       |   | Smaller      reporting company x |
| (Do      not check if a smaller reporting company) |   |                                  |

----

| Yes   x | No   o |
|------------------------|-----------------------|

----

|                                                                                                                                                                                             |   | Page   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------|
| PART I      - FINANCIAL INFORMATION                                                                                                                                                         |   |   |
|                                                                                                                                                                                             |   |   |
| Item      1  Financial Statements:                                                                                                                                                          |   | 4      |
|                                                                                                                                                                                             |   |   |
| Balance      Sheets as of  December 31, 2009 (unaudited) and March 31,      2009                                                                                                       |   | 5      |
|                                                                                                                                                                                             |   |   |
| Statements      of Operations for the three months and nine months ended December 31, 2009      and 2008, and the period of March 13, 2008 (Inception) to December      31, 2009(unaudited) |   | 6      |
|                                                                                                                                                                                             |   |   |
| Statements      of Cash Flows for the nine months ended December 31, 2009      and 2008, and the period of March 13, 2008 (Inception) to December      31, 2009(unaudited)   |   | 7      |
|                                                                                                                                                                                             |   |   |
| Notes      to Unaudited  Financial Statements                                                                                                                                               |   | 8      |
|                                                                                                                                                                                             |   |   |
| Item      2  Management’s Discussion and Analysis of Financial Condition and      Results of Operations                                                                               |   | 9      |
|                                                                                                                                                                                             |   |   |
| Item      3  Quantitative and Qualitative Disclosures About Market      Risk                                                                                                                |   | 11     |
|                                                                                                                                                                                             |   |   |
| Item      4T  Controls and Procedures                                                                                                                                                       |   | 11     |
|                                                                                                                                                                                             |   |   |
| PART      II – OTHER INFORMATION                                                                                                                                                           |   |   |
|                                                                                                                                                                                             |   |   |
|                                                                                                                                                                                             |   |   |
| Item      1   Legal Proceedings                                                                                                                                                        |   | 12     |
|                                                                                                                                                                                             |   |   |
| Item      1A.  Risk Factors                                                                                                                                                                 |   | 13     |
|                                                                                                                                                                                             |   |   |
| Item      2   Unregistered Sales of  Equity Securities and Use of      Proceeds                                                                                                   |   | 13     |
|                                                                                                                                                                                             |   |   |
| Item      3   Defaults upon Senior Securities                                                                                                                                          |   | 13     |
|                                                                                                                                                                                             |   |   |
| Item      4   Submission of Matters to a Vote of Security      Holders                                                                                                                 |   | 13     |
|                                                                                                                                                                                             |   |   |
| Item      5  Other Information                                                                                                                                                              |   | 13     |
|                                                                                                                                                                                             |   |   |
| Item      6  Exhibits                                                                                                                                                                       |   | 13     |
|                                                                                                                                                                                             |   |   |
| Signatures                                                                                                                                                                                       |   | 14     |

----

| Item      1. | Financial      Statements. |
|--------------|----------------------------|

----

| MEDISTAFF      CORPORATION                                                                                                                                                           |                   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------|
| (A      Development Stage Enterprise)                                                                                                                                                |                   |
| Balance      Sheets                                                                                                                                                                  |                   |
|                                                                                                                                                                                 |                   |   |   |   |   |   |
|                                                                                                                                                                                 | December      31, 2009 |   | March      31, 2009 |   |
|                                                                                                                                                                                 |
|                                                                                                                                                                                 |
|                                                                                                                                                                                 | (unaudited)            |   |   |   |   |
| ASSETS                                                                                                                                                                               |                   |
|                                                                                                                                                                                 |                   |   |   |   |   |   |
| Current      assets                                                                                                                                                                  |                   |   |   |   |   |   |
| Cash                                                                                                                                                                                 |                   | $ | 10,904 |   |   | $ | 13,055 |   |
|                                                                                                                                                                                 |                   |   |   |   |   |   |   |   |
| Total      current assets                                                                                                                                                            |                   |   | 10,904 |   |   |   | 13,055 |   |
|                                                                                                                                                                                 |                   |   |   |   |   |   |   |   |
| Total      assets                                                                                                                                                                    |                   | $ | 10,904 |   |   | $ | 13,055 |   |
|                                                                                                                                                                                 |                   |   |   |   |   |   |   |   |
| LIABILITIES      AND STOCKHOLDERS' EQUITY                                                                                                                                            |                   |
|                                                                                                                                                                                 |                   |   |   |   |   |   |   |   |
| Current      liabilities                                                                                                                                                             |                   |   |   |   |   |   |   |   |
| Accounts      payable and accrued liabilities                                                                                                                                        |                   | $ | 1,950 |   |   | $ | 3,090 |   |
|                                                                                                                                                                                 |                   |   |   |   |   |   |   |   |
| Total      current liabilities                                                                                                                                                       |                   |   | 1,950 |   |   |   | 3,090 |   |
|                                                                                                                                                                                 |                   |   |   |   |   |   |   |   |
| Stockholders'      Equity                                                                                                                                                            |                   |   |   |   |   |   |   |   |
| Common      stock, $.001 par value; 75,000,000 shares authorized; 5,429,016      and  5,331,016 issued and outstanding at December 31, 2009 and      March 31, 2009, resp. |                   |   | 5,429 |   |   |   | 5,331 |   |
| Additional      paid in capital                                                                                                                                                      |                   |   | 35,846 |   |   |   | 26,144 |   |
| Deficit      accumulated during the development stage                                                                                                                                |                   |   | (32,321 | ) |   |   | (21,510 | ) |
| Total      stockholders' equity                                                                                                                                                      |                   |   | 8,954 |   |   |   | 9,965 |   |
|                                                                                                                                                                                 |                   |   |   |   |   |   |   |   |
| Total      liabilities and stockholders' equity                                                                                                                                      |                   | $ | 10,904 |   |   | $ | 13,055 |   |
|                                                                                                                                                                                 |                   |   |   |   |   |   |   |   |
| See      accompanying notes to unaudited financial statements                                                                                                                        |                   |

----

| MEDISTAFF      CORPORATION                                    |   |
|---------------------------------------------------------------|--------|
| (A      Development Stage Enterprise)                         |   |
| Statements      of Operations (unaudited)                     |   |
|                                                          |   |   |   |   |   |   |   |   |   |   |   |   |   | For      the period from March 13, 2008 (inception) to December 31,      2009 |   |
|                                                          |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                          |   | Three      months ended December 31, |   |   | Nine      months ended December 31, |   |
|                                                          |   | 2009 |   |   | 2008 |   |   | 2009 |   |   | 2008 |   |
|                                                          |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Revenue                                                       |   | $ | - |   |   | $ | - |   |   | $ | - |   |   | $ | - |   |   | $ | - |   |
|                                                          |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Operating      expenses                                       |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Professional      fees                                        |   |   | 2,326 |   |   |   | 1,500 |   |   |   | 10,504 |   |   |   | 19,875 |   |   |   | 31,879 |   |
| Other      general & administrative                       |   |   | 33 |   |   |   | - |   |   |   | 400 |   |   |   | 50 |   |   |   | 450 |   |
| Total      operating expenses                                 |   |   | 2,359 |   |   |   | 1,500 |   |   |   | 10,904 |   |   |   | 19,925 |   |   |   | 32,329 |   |
|                                                          |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Other      income (expense)                                   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Interest      expense                                         |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | (90 | ) |
| Interest      income                                          |   |   | - |   |   |   | 1 |   |   |   | 3 |   |   |   | 1 |   |   |   | 8 |   |
| Other      income                                             |   |   | - |   |   |   | - |   |   |   | 90 |   |   |   | - |   |   |   | 90 |   |
| Total      other income (expense)                             |   |   | - |   |   |   | 1 |   |   |   | 93 |   |   |   | 1 |   |   |   | 8 |   |
|                                                          |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Net      loss available to common stockholders                |   | $ | (2,359 | ) |   | $ | (1,499 | ) |   | $ | (10,811 | ) |   | $ | (19,924 | ) |   | $ | (32,321 | ) |
|                                                          |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Basic      and diluted loss per common share                  |   | $ | (0.00 | ) |   | $ | (0.00 | ) |   | $ | (0.00 | ) |   | $ | (0.00 | ) |   |   |   |   |
|                                                          |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Weighted      average common shares outstanding               |   |   | 5,377,644 |   |   |   | 5,331,016 |   |   |   | 5,346,615 |   |   |   | 5,303,183 |   |   |   |   |   |
|                                                          |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| See      accompanying notes to unaudited financial statements |   |

----

| MEDISTAFF      CORPORATION                                                                    |                                |
|-----------------------------------------------------------------------------------------------|-------------------------------------|
| (A      Development Stage Enterprise)                                                         |                                |
| Statements      of Cash Flows (unaudited)                                                     |                                |
|                                                                                          |                                |   |   |   |   |   | For      the period from March 13, 2008 (inception) to December 31,      2009 |   |
|                                                                                          |                                |   |   |   |   |   |
|                                                                                          |                                |   |   |   |   |   |
|                                                                                          | Nine      months ended December 31, |   |
|                                                                                          | 2009                                |   | 2008 |   |
| Cash      flows from operating activities                                                     |                                |   |   |   |   |   |   |
| Net      loss                                                                                 |                                | $ | (10,811 | ) |   | $ | (19,924 | ) |   | $ | (32,321 | ) |
| Adjustments      to reconcile net loss to net cash used in operating      activities:         |                                |
| Common      stock issued for services                                                         |                                |   | - |   |   |   | - |   |   |   | 1,375 |   |
| Changes      in operating assets and liabilities:                                             |                                |   |   |   |   |   |   |   |
| Decrease      in prepaid expenses                                                             |                                |   | - |   |   |   | 13,875 |   |   |   | - |   |
| Increase      (decrease) in accounts payable and accrued liabilities                          |                                |   | (1,140 | ) |   |   | 4,500 |   |   |   | 1,950 |   |
| Net      cash used in operating activities                                                    |                                |   | (11,951 | ) |   |   | (1,549 | ) |   |   | (28,996 | ) |
|                                                                                          |                                |   |   |   |   |   |   |   |   |   |   |   |
| Cash      flows from investing activities                                                     |                                |   | - |   |   |   | - |   |   |   | - |   |
|                                                                                          |                                |   |   |   |   |   |   |   |   |   |   |   |
| Cash      flows from financing activities                                                     |                                |   |   |   |   |   |   |   |   |
| Proceeds      from sale of stock (net of offering costs)                                      |                                |   | 9,800 |   |   |   | 5,100 |   |   |   | 39,900 |   |
| Net      cash provided by financing activities                                                |                                |   | 9,800 |   |   |   | 5,100 |   |   |   | 39,900 |   |
|                                                                                          |                                |   |   |   |   |   |   |   |   |   |   |   |
| Increase      (decrease) in cash                                                              |                                |   | (2,151 | ) |   |   | 3,551 |   |   |   | 10,904 |   |
|                                                                                          |                                |   |   |   |   |   |   |   |   |   |   |   |
| Cash      at beginning of period                                                              |                                |   | 13,055 |   |   |   | 12,500 |   |   |   | - |   |
|                                                                                          |                                |   |   |   |   |   |   |   |   |   |   |   |
| Cash      at end of period                                                                    |                                | $ | 10,904 |   |   | $ | 16,051 |   |   | $ | 10,904 |   |
|                                                                                          |                                |   |   |   |   |   |   |   |   |   |   |   |
| Supplemental      disclosure of non-cash investing and financing activities:                  |                                |
| Issuance      of 275,016 shares of common stock for professional and consulting      services |                                | $ | - |   |   | $ | - |   |   | $ | 1,375 |   |
|                                                                                          |                                |   |   |   |   |   |   |   |   |   |   |   |
| Supplemental      cash flow Information:                                                      |                                |   |   |   |   |   |   |   |   |
| Cash      paid for interest                                                                   |                                | $ | - |   |   | $ | - |   |   | $ | - |   |
| Cash      paid for income taxes                                                               |                                | $ | - |   |   | $ | - |   |   | $ | - |   |
|                                                                                          |                                |   |   |   |   |   |   |   |   |   |   |   |
| See      accompanying notes to unaudited financial statements                                 |                                |

----

----

| Item      2. | Management’s      Discussion and Analysis of Financial Condition and Results of      Operations. |
|--------------|--------------------------------------------------------------------------------------------------------|

|   | · | Hospitals      and teaching facilities,              |
|--------|--------|------------------------------------------------------|
|   | · | Clinics      and nursing homes, and                  |
|   | · | Organizations,      such as corporations or schools. |

----

----

| Item      3. | Quantitative      and Qualitative Disclosures about MarketRisk. |
|--------------|-----------------------------------------------------------------|

| Item      4T. | Controls      and Procedures |
|---------------|------------------------------|

| (a) | Evaluation of Disclosure Controls and      Procedures |
|-----|-------------------------------------------------------|

----

|           ● | The      Company’s Audit Committee does not function as an Audit Committee should,      since there is a lack of independent directors on the Committee and the      Board of Directors has not identified an “expert,” one who is      knowledgeable about reporting and financial statements requirements, to      serve on the Audit Committee. |
|---------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|           ● | The      Company has limited segregation of duties which is not consistent with      good internal control procedures. |
|---------------------------------------|------------------------------------------------------------------------------------------------------------------------|

|           ● | The      Company does not have a written internal control procedures manual that      outlines the duties and reporting requirements of the Directors and any      staff to be hired in the future.  This lack of a written      internal control procedures manual does not meet the requirements of the      SEC or good internal control. |
|---------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|           ● | There      are no effective controls instituted over financial disclosure and the      reporting processes. |
|---------------------------------------|-------------------------------------------------------------------------------------------------------------|

| (b) | Changes in Internal  Controls |
|-----|-------------------------------|

| Item      1. | Legal      Proceedings. |
|--------------|-------------------------|

----

|  Item 1A. | Risk      Factors. |
|----------------|--------------------|

| Item      2. | Unregistered      Sales of Equity Securities and use ofProceeds |
|--------------|-----------------------------------------------------------------|

| Item      3. | Defaults      upon Senior Securities. |
|--------------|---------------------------------------|

| Item      4. | Submission      of Matters to a Vote of SecurityHolders. |
|--------------|----------------------------------------------------------|

| Item      5. | Other      Information. |
|--------------|-------------------------|

| Item      6. | Exhibits. |
|--------------|-----------|
|         |      |

|   | (a)    | Exhibits      furnished as Exhibits hereto: |
|--------|--------|---------------------------------------------|
|   |   |

| Exhibit No. | Description |
|-------------|-------------|

| 31.1 |   | 8650      SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL      OFFICER |
|------|--------|-------------------------------------------------------------------------------------------------|

| 32.1 |   | CERTIFICATION      PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF      THE SARBANES-OXLEY ACT OF 2002  |
|------|--------|---------------------------------------------------------------------------------------------------------------------------------------|

----

|                        | MediStaff  Corporation |
|-----------------------------|----------------------------------|
|                        |                             |   |
| Date:      February 5, 2010 | By:                              | /s/      Dale Byers |
|                        |                             | Dale      Byers |
|                        |                             | Chief      Financial Officer, Secretary and Treasurer |
|                        |                             | (principal      financial and accounting officer) |
|                        |                             |   |
| Date:      February 5, 2010 | By:                              | /s/      Dale Byers |
|                        |                             | Dale      Byers |
|                        |                             | President      and Chief Executive Officer |

----